Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.45p
   
  • Change Today:
      0.000p
  • 52 Week High: 14.13
  • 52 Week Low: 3.41
  • Currency: UK Pounds
  • Shares Issued: 132.35m
  • Volume: 49,024
  • Market Cap: £4.57m
  • RiskGrade: 435

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
12.41% below the market average12.41% below the market average12.41% below the market average12.41% below the market average12.41% below the market average
51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
73.75% below the market average73.75% below the market average73.75% below the market average73.75% below the market average73.75% below the market average
36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average
Price Chg 3m
85.99% below the market average85.99% below the market average85.99% below the market average85.99% below the market average85.99% below the market average
43.86% below the sector average43.86% below the sector average43.86% below the sector average43.86% below the sector average43.86% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
71.73% below the market average71.73% below the market average71.73% below the market average71.73% below the market average71.73% below the market average
73.58% below the sector average73.58% below the sector average73.58% below the sector average73.58% below the sector average73.58% below the sector average
Momentum 20
23.6% below the market average23.6% below the market average23.6% below the market average23.6% below the market average23.6% below the market average
13.21% below the sector average13.21% below the sector average13.21% below the sector average13.21% below the sector average13.21% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
68.65% below the market average68.65% below the market average68.65% below the market average68.65% below the market average68.65% below the market average
18.52% below the sector average18.52% below the sector average18.52% below the sector average18.52% below the sector average18.52% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
80.77% below the market average80.77% below the market average80.77% below the market average80.77% below the market average80.77% below the market average
84.91% below the sector average84.91% below the sector average84.91% below the sector average84.91% below the sector average84.91% below the sector average
Cash
59.52% below the market average59.52% below the market average59.52% below the market average59.52% below the market average59.52% below the market average
70.37% below the sector average70.37% below the sector average70.37% below the sector average70.37% below the sector average70.37% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 3.45p
Change Today 0.000p
% Change 0.00 %
52 Week High 14.13
52 Week Low 3.41
Volume 49,024
Shares Issued 132.35m
Market Cap £4.57m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.74% below the market average20.74% below the market average20.74% below the market average20.74% below the market average20.74% below the market average
13.21% above the sector average13.21% above the sector average13.21% above the sector average13.21% above the sector average13.21% above the sector average
Price Trend
94.61% below the market average94.61% below the market average94.61% below the market average94.61% below the market average94.61% below the market average
89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average89.47% below the sector average
Income Not Available
Growth Not Available

Valirx Dividends

No dividends found

Trades for 24-Apr-2024

Time Volume / Share Price
15:06 18,000 @ 3.45p
14:37 1,500 @ 3.41p
13:22 29,524 @ 3.41p

Valirx Key Personnel

CFO Gerald Desler
CEO Suzanne Dilly

Top of Page